NASDAQ Biotechnology Total Retu XNBI Indice
4239.33 USD
{{ price }}
-1.961071%
{{change_pct}}%
PAESE
stati Uniti
Borsa valori
Nasdaq GIDS
MIN - MAX [24 ore]
4231.82
-
4352.07 USD
Numero di componenti
190
NASDAQ Biotechnology Total Retu Grafico dei prezzi
Top 5 Vincitori delle Ultime 24 Ore
| BLUE | bluebird bio | +50.45% | |
|---|---|---|---|
| EXEL | Exelixis | +20.84% | |
| PCRX | Pacira BioSciences | +4.49% | |
| DBVT | DBV | +4.46% | |
| JAZZ | Jazz Pharmaceuticals | +3.58% |
Top 5 Perdenti delle Ultime 24 Ore
| NSTG | NanoString | -37.43% | |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals | -15.57% | |
| OMER | Omeros | -11.29% | |
| PRTA | Prothena | -9.29% | |
| MCRB | Seres Therapeutics | -8.14% |
NASDAQ Biotechnology Total Retu XNBI PANORAMICA FINANZIARIA E DI TRADING
| NASDAQ Biotechnology Total Retu Prezzo dell'Indice | 4239.33 USD |
| Chiusura Precedente | 4472.96 USD |
| Apertura | 4476.26 USD |
| Prezzo di Acquisto | 0 USD x 0 |
| Prezzo di Vendita | 0 USD x 0 |
| Variazione Giornaliera | 4464.53 - 4532.84 USD |
| Variazione a 52 Settimane | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Volume Medio | N/A |
Informazioni di trading
NASDAQ Biotechnology Total Retu Storico dei prezzi dell'Indice
| Massimo a 52 Settimane | 4532.84 USD |
| Minimo a 52 Settimane | 4464.53 USD |
| Media Mobile a 50 Giorni | N/A |
| Media Mobile a 200 Giorni | N/A |
XNBI Statistiche dell'indice
| Volume Medio (3 Mesi) | N/A |
| Vol. Medio Giornaliero (10 Giorni) | N/A |
D&R per l'Indice NASDAQ Biotechnology Total Retu
Qual è il prezzo attuale dell'Indice XNBI?
Il prezzo dell'Indice NASDAQ Biotechnology Total Retu XNBI oggi è di 4239.33 USD.
Come acquistare l'Indice NASDAQ Biotechnology Total Retu?
Puoi acquistare l'indice XNBI sulla borsa Nasdaq GIDS. Contatta il tuo consulente finanziario per selezionare un broker.
Qual è la sigla borsistica dell'Indice NASDAQ Biotechnology Total Retu?
La sigla (o ticker) dell'Indice NASDAQ Biotechnology Total Retu è XNBI.
Quanti componenti contiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu contiene 190 componenti.
A quale paese appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento a United States.
A quale borsa appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento alla borsa Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPONENTI
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $262.28 — |
-3.02
|
$141.03B — | $3.93M — | $261.43 — | $270.34 — | $141.03B — | 23.93 | $10.96 — |
| Gilead Sciences GILD | $98.38 — |
-3.01
|
$122.48B — | $10.02M — | $98.08 — | $101.73 — | $122.48B — | 20.66 | $4.76 — |
| Vertex Pharmaceuticals Incorporated VRTX | $421.16 — |
-2.51
|
$108.15B — | $2.06M — | $417 — | $433.41 — | $108.15B — | 0 | -$3.83 — |
| Regeneron Pharmaceuticals REGN | $571.36 — |
-0.49
|
$61.69B — | $1.66M — | $567.75 — | $580.56 — | $61.69B — | 14.51 | $39.37 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $267.55 — |
+0.26
|
$34.89B — | $650.69K — | $261.85 — | $270 — | $34.89B — | 0 | -$2.09 — |
| Biogen BIIB | $120.37 — |
-2.27
|
$17.64B — | $1.5M — | $120.04 — | $123.74 — | $17.64B — | 11.89 | $10.12 — |
| United Therapeutics UTHR | $299.68 — |
-2.72
|
$13.52B — | $522.83K — | $298.69 — | $307.62 — | $13.52B — | 11.93 | $25.11 — |
| Illumina ILMN | $78.21 — |
-2.6
|
$12.38B — | $3.73M — | $77.55 — | $81.64 — | $12.38B — | 0 | -$6.08 — |
| Exelixis EXEL | $44.65 — |
+20.84
|
$12.3B — | $12.84M — | $40.47 — | $45.29 — | $12.3B — | 25.36 | $1.76 — |
| Insmed Incorporated INSM | $65.61 — |
-0.15
|
$11.95B — | $2.09M — | $65.07 — | $66.66 — | $11.95B — | 0 | -$5.93 — |
| Incyte INCY | $61.16 — |
+0.58
|
$11.84B — | $2.06M — | $59.15 — | $62.5 — | $11.84B — | 305.80 | $0.2 — |
| Neurocrine Biosciences NBIX | $118.78 — |
+1.63
|
$11.76B — | $1.67M — | $116 — | $121.85 — | $11.76B — | 40.26 | $2.95 — |
| BioMarin Pharmaceutical BMRN | $58.7 — |
-1.81
|
$11.26B — | $1.83M — | $58.52 — | $60.03 — | $11.26B — | 21.74 | $2.7 — |
| Qiagen QGEN | $41.15 — |
-2.28
|
$8.91B — | $1.78M — | $41.13 — | $42.55 — | $8.91B — | 95.69 | $0.43 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Bio-Techne TECH | $47.86 — |
-7.27
|
$7.5B — | $2.85M — | $47.75 — | $51.34 — | $7.5B — | 57.66 | $0.83 — |
| Repligen RGEN | $128.04 — |
-2.67
|
$7.19B — | $480.69K — | $126.5 — | $132.1 — | $7.19B — | 0 | -$0.42 — |
| Jazz Pharmaceuticals JAZZ | $106.59 — |
+3.58
|
$6.57B — | $1.85M — | $103.88 — | $108.69 — | $6.57B — | 14.50 | $7.35 — |
| Blueprint Medicines BPMC | $97.51 — |
-1.91
|
$6.3B — | $420.27K — | $97.49 — | $100.37 — | $6.3B — | 0 | -$2.51 — |
- {{ link.label }} {{link}}